| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,834 |
4,197 |
$825K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,383 |
5,730 |
$537K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,251 |
2,551 |
$460K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
3,977 |
1,182 |
$283K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,032 |
760 |
$184K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,737 |
1,554 |
$149K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
2,737 |
1,036 |
$138K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,105 |
1,726 |
$104K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,269 |
1,363 |
$104K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
787 |
482 |
$101K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,354 |
935 |
$101K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
291 |
233 |
$70K |
| 94761 |
|
1,111 |
887 |
$64K |
| 80053 |
Comprehensive metabolic panel |
7,498 |
6,142 |
$52K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,960 |
6,367 |
$36K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
997 |
426 |
$29K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,173 |
484 |
$28K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,062 |
847 |
$27K |
| 70450 |
Computed tomography, head or brain; without contrast material |
422 |
391 |
$27K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
178 |
170 |
$26K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,055 |
1,886 |
$22K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
27 |
25 |
$22K |
| 93041 |
|
692 |
615 |
$18K |
| 36415 |
Collection of venous blood by venipuncture |
7,285 |
5,837 |
$17K |
| 84145 |
|
1,011 |
896 |
$17K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
597 |
548 |
$15K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
896 |
684 |
$15K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
274 |
246 |
$14K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
805 |
710 |
$14K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
213 |
182 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
232 |
194 |
$12K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
158 |
149 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
844 |
459 |
$11K |
| 84484 |
|
1,150 |
838 |
$11K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
734 |
612 |
$10K |
| 71046 |
Radiologic examination, chest; 2 views |
802 |
759 |
$9K |
| 81001 |
|
2,913 |
2,542 |
$9K |
| 87088 |
|
1,291 |
1,149 |
$8K |
| 86140 |
|
1,526 |
1,329 |
$8K |
| 83880 |
|
437 |
380 |
$7K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
202 |
125 |
$6K |
| 83735 |
|
1,209 |
990 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
104 |
66 |
$5K |
| 80061 |
Lipid panel |
636 |
611 |
$5K |
| 87077 |
|
1,131 |
916 |
$5K |
| 85610 |
|
985 |
700 |
$5K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
108 |
97 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
148 |
123 |
$4K |
| 80306 |
|
377 |
346 |
$4K |
| 83690 |
|
686 |
605 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
758 |
726 |
$4K |
| 87186 |
|
799 |
627 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
868 |
747 |
$4K |
| 87040 |
|
351 |
212 |
$3K |
| 83605 |
|
292 |
257 |
$3K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
384 |
336 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
100 |
67 |
$3K |
| 84439 |
|
386 |
371 |
$3K |
| 82550 |
|
284 |
233 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
446 |
372 |
$3K |
| 84703 |
|
358 |
340 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
353 |
296 |
$3K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
113 |
102 |
$2K |
| 87081 |
|
366 |
337 |
$2K |
| 85027 |
|
344 |
314 |
$2K |
| 97113 |
|
48 |
25 |
$2K |
| 82150 |
|
242 |
226 |
$2K |
| 82962 |
|
291 |
127 |
$2K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
12 |
12 |
$2K |
| 85652 |
|
338 |
320 |
$2K |
| 85379 |
|
92 |
88 |
$1K |
| 76830 |
Ultrasound, transvaginal |
21 |
13 |
$1K |
| 87070 |
|
142 |
131 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
96 |
96 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
191 |
174 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
87 |
76 |
$984.49 |
| 87420 |
|
80 |
76 |
$959.93 |
| 94760 |
|
20 |
12 |
$895.68 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
25 |
24 |
$865.54 |
| 81025 |
|
135 |
117 |
$864.64 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
25 |
24 |
$864.22 |
| 86850 |
|
139 |
118 |
$833.70 |
| 73630 |
|
52 |
51 |
$762.35 |
| 94664 |
|
27 |
26 |
$751.38 |
| 97161 |
|
14 |
14 |
$741.95 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
29 |
29 |
$739.05 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
28 |
27 |
$730.76 |
| 97162 |
|
12 |
12 |
$619.72 |
| 0002A |
|
16 |
16 |
$600.00 |
| 0001A |
|
13 |
13 |
$520.00 |
| 86900 |
|
131 |
113 |
$508.43 |
| 0011A |
|
15 |
15 |
$480.00 |
| 0012A |
|
15 |
15 |
$440.00 |
| 86901 |
|
131 |
113 |
$415.25 |
| 85730 |
|
40 |
37 |
$297.62 |
| 85007 |
|
68 |
67 |
$266.01 |
| 73110 |
|
14 |
12 |
$236.50 |
| 82570 |
|
61 |
54 |
$223.44 |
| 73610 |
|
14 |
14 |
$191.14 |
| 82607 |
|
13 |
12 |
$183.60 |
| 76857 |
|
15 |
12 |
$175.14 |
| 99001 |
|
115 |
114 |
$150.00 |
| 80320 |
|
347 |
296 |
$88.11 |
| 81000 |
|
27 |
25 |
$38.58 |
| 84100 |
|
17 |
13 |
$26.38 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
81 |
51 |
$5.01 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
74 |
64 |
$2.03 |
| A9270 |
Non-covered item or service |
1,032 |
665 |
$1.67 |
| 96376 |
|
28 |
25 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
52 |
41 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
15 |
13 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
28 |
27 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
37 |
31 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
19 |
15 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
13 |
12 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
33 |
32 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
37 |
36 |
$0.00 |